Northwest Biotherapeutics Inc (NWBO) stock
NWBOOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.16−0.00 (-0.88%)
Close on Oct 19, 2026Market cap $254.79MP/E –Yield –
Northwest Biotherapeutics ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Northwest Biotherapeutics's ebitda for the twelve months ending Jun 30, 2026 was -$47.61M. For fiscal 2025 it was -$57.85M. The highest annual figure on record is -$15.35M in fiscal 2010.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$57.85M | – |
| FY2024 | Dec 31, 2024 | -$64.76M | – |
| FY2023 | Dec 31, 2023 | -$53.98M | – |
| FY2022 | Dec 31, 2022 | -$65.93M | – |
| FY2021 | Dec 31, 2021 | -$52.38M | – |
| FY2020 | Dec 31, 2020 | -$86.52M | – |
| FY2019 | Dec 31, 2019 | -$27.96M | – |
| FY2018 | Dec 31, 2018 | -$40.19M | – |
| FY2017 | Dec 31, 2017 | -$54.24M | – |
| FY2016 | Dec 31, 2016 | -$79.08M | – |
| FY2015 | Dec 31, 2015 | -$126.23M | – |
| FY2014 | Dec 31, 2014 | -$101.13M | – |
| FY2013 | Dec 31, 2013 | -$55.46M | – |
| FY2012 | Dec 31, 2012 | -$43.81M | – |
| FY2011 | Dec 31, 2011 | -$26.78M | – |
| FY2010 | Dec 31, 2010 | -$15.35M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$10.83M | – |
| Q1 FY2026 | Mar 31, 2026 | -$10.13M | – |
| Q4 FY2025 | Dec 31, 2025 | -$12.74M | – |
| Q3 FY2025 | Sep 30, 2025 | -$13.91M | – |
| Q2 FY2025 | Jun 30, 2025 | -$14.33M | – |
| Q1 FY2025 | Mar 31, 2025 | -$16.88M | – |
| Q4 FY2024 | Dec 31, 2024 | -$18.06M | – |
| Q3 FY2024 | Sep 30, 2024 | -$14.40M | – |
| Q2 FY2024 | Jun 30, 2024 | -$16.96M | – |
| Q1 FY2024 | Mar 31, 2024 | -$15.34M | – |
| Q4 FY2023 | Dec 31, 2023 | -$14.72M | – |
| Q3 FY2023 | Sep 30, 2023 | -$13.41M | – |
| Q2 FY2023 | Jun 30, 2023 | -$13.23M | – |
| Q1 FY2023 | Mar 31, 2023 | -$12.63M | – |
| Q4 FY2022 | Dec 31, 2022 | -$17.86M | – |
| Q3 FY2022 | Sep 30, 2022 | -$15.31M | – |
| Q2 FY2022 | Jun 30, 2022 | -$20.58M | – |
| Q1 FY2022 | Mar 31, 2022 | -$12.19M | – |
| Q4 FY2021 | Dec 31, 2021 | -$10.59M | – |
| Q3 FY2021 | Sep 30, 2021 | -$9.95M | – |
| Q4 FY2020 | Dec 31, 2020 | -$23.31M | – |
| Q3 FY2020 | Sep 30, 2020 | -$47.86M | – |
| Q2 FY2020 | Jun 30, 2020 | -$7.53M | – |
| Q1 FY2020 | Mar 31, 2020 | -$7.82M | – |
| Q4 FY2019 | Dec 31, 2019 | -$6.73M | – |
| Q3 FY2019 | Sep 30, 2019 | -$6.58M | – |
| Q2 FY2019 | Jun 30, 2019 | -$6.63M | – |
| Q1 FY2019 | Mar 31, 2019 | -$7.76M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.76M | – |
| Q3 FY2018 | Sep 30, 2018 | -$8.98M | – |
| Q2 FY2018 | Jun 30, 2018 | -$20.00M | – |
| Q1 FY2018 | Mar 31, 2018 | -$8.45M | – |
| Q4 FY2017 | Dec 31, 2017 | -$17.68M | – |
| Q4 FY2016 | Dec 31, 2016 | -$21.19M | – |
| Q3 FY2016 | Sep 30, 2016 | -$25.46M | – |
| Q2 FY2016 | Jun 30, 2016 | -$14.96M | – |
| Q1 FY2016 | Mar 31, 2016 | -$17.47M | – |
| Q4 FY2015 | Dec 31, 2015 | -$51.37M | – |
See a number that looks wrong?